Viral suppression following switch to second-line antiretroviral therapy: associations with NRTI resistance and 'sub-therapeutic' drug concentrations prior to switch.

Johnston, V; Cohen, K; Wiesner, L; Morris, L; Ledwaba, J; Fielding, KL; Charalambous, S; Churchyard, G; Phillips, A; Grant, AD; (2013) Viral suppression following switch to second-line antiretroviral therapy: associations with NRTI resistance and 'sub-therapeutic' drug concentrations prior to switch. The Journal of infectious diseases, 209 (5). pp. 711-20. ISSN 0022-1899 DOI: https://doi.org/10.1093/infdis/jit411

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/infdis/jit411

Abstract

Share

Download

Filename: J Infect Dis.-2013-Johnston-infdis_jit411.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar